Compare SOLS & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOLS | UHS |
|---|---|---|
| Founded | 2025 | 1978 |
| Country | United States | United States |
| Employees | 4400 | N/A |
| Industry | Aerospace | Hospital/Nursing Management |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 11.4B |
| IPO Year | N/A | 1994 |
| Metric | SOLS | UHS |
|---|---|---|
| Price | $77.51 | $180.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $72.75 | ★ $233.00 |
| AVG Volume (30 Days) | ★ 1.9M | 665.5K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | 0.38% | ★ 0.44% |
| EPS Growth | N/A | ★ 37.34 |
| EPS | N/A | ★ 23.10 |
| Revenue | N/A | ★ $17,364,829,000.00 |
| Revenue This Year | $6.46 | $7.70 |
| Revenue Next Year | $5.46 | $4.96 |
| P/E Ratio | $54.31 | ★ $7.84 |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $40.43 | $152.33 |
| 52 Week High | $84.44 | $246.33 |
| Indicator | SOLS | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 34.96 |
| Support Level | $69.12 | $152.33 |
| Resistance Level | $83.07 | $187.79 |
| Average True Range (ATR) | 3.39 | 4.79 |
| MACD | 0.31 | 0.31 |
| Stochastic Oscillator | 80.78 | 32.59 |
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
Universal Health Services primarily offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the US, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.